Todisco Joseph
Transaction: 02/04/2026
BUY
Change
+77,156
Price
Not reported
Filing
02/06/2026
Type
BUY
CorMedix Inc.
CRMD • Biotechnology
$7.60
▲ +0.03 (+0.40%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$638.60M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 52.3%Positive revenue growth · 440.3%Positive free cash flow · 2.4Reasonable earnings multiple · 5.14Manageable debt level · 0.37
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.60
Change0.40%
Market Cap$638.60M
52W Range6.13 - 14.96
Beta1.50
Gross Margin88.46%
Oper. Margin48.17%
Profit Margin52.31%
Debt/Eq0.37
Current Ratio2.11
Quick Ratio1.94
Target$13.50
Price$7.60
Change0.40%
Market Cap$638.60M
52W Range6.13 - 14.96
Beta1.50
Gross Margin88.46%
Oper. Margin48.17%
Profit Margin52.31%
Debt/Eq0.37
Current Ratio2.11
Quick Ratio1.94
Target$13.50
Target Upside77.63%
Target Median$13.50
Target Range13.00 - 14.00
Volume6.03M
Avg Volume1.19M
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
85
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
94/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Stable or improving margins · 52.3%Positive revenue growth · 440.3%Positive free cash flow · 2.4Reasonable earnings multiple · 5.14Manageable debt level · 0.37Healthy liquidity · 2.11
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$13.00
Mean
$13.50
Median
$13.50
High
$14.00
Insider Transactions
Recent executive and insider activity
Hurlburt Elizabeth
Transaction: 02/04/2026
BUY
Change
+36,006
Price
Not reported
Filing
02/06/2026
Type
BUY
Zelnick Kaufman Beth
Transaction: 02/04/2026
BUY
Change
+36,006
Price
Not reported
Filing
02/06/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Todisco Joseph | BUY | +77,156 | Not reported | 02/04/2026 | 02/06/2026 |
| Hurlburt Elizabeth | BUY | +36,006 | Not reported | 02/04/2026 | 02/06/2026 |
| Zelnick Kaufman Beth | BUY | +36,006 | Not reported | 02/04/2026 | 02/06/2026 |
| Stewart Robert A | BUY | +30,453 | Not reported | 01/26/2026 | 01/27/2026 |
| Duncan Gregory Scott | BUY | +30,453 | Not reported | 01/26/2026 | 01/27/2026 |
| DUNTON ALAN W | BUY | +30,453 | Not reported | 01/26/2026 | 01/27/2026 |
| Lefkowitz Steven W | BUY | +30,453 | Not reported | 01/26/2026 | 01/27/2026 |
| Dillione Janet | BUY | +30,453 | Not reported | 01/26/2026 | 01/27/2026 |
| Kaplan Myron | BUY | +30,453 | Not reported | 01/26/2026 | 01/27/2026 |
| Todisco Joseph | SELL | -27,306 | $7.27 | 01/23/2026 | 01/27/2026 |
| Hurlburt Elizabeth | SELL | -10,778 | $7.27 | 01/23/2026 | 01/27/2026 |
| Zelnick Kaufman Beth | SELL | -8,803 | $7.27 | 01/23/2026 | 01/27/2026 |
| Blum Susan | SELL | -9,767 | $7.27 | 01/23/2026 | 01/27/2026 |
| Dillione Janet | SELL | -10,000 | $6.88 | 01/21/2026 | 01/22/2026 |
| Todisco Joseph | SELL | -22,665 | $6.78 | 01/17/2026 | 01/20/2026 |
| Todisco Joseph | SELL | -29,585 | $3.38 | 01/16/2026 | 01/20/2026 |
| Todisco Joseph | BUY | +29,585 | $3.38 | 01/16/2026 | 01/20/2026 |
| Todisco Joseph | SELL | -17,417 | $7.15 | 01/12/2026 | 01/20/2026 |
| Hurlburt Elizabeth | SELL | -5,794 | $7.15 | 01/12/2026 | 01/20/2026 |
| Seckler Michael David | OTHER | 0 | Not reported | 01/08/2026 | 01/15/2026 |